Page last updated: 2024-12-08

arabinofuranose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

arabinofuranose: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

L-arabinofuranose : The five-membered ring form of L-arabinose. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID440921
CHEBI ID6178
SCHEMBL ID447758
MeSH IDM0394564

Synonyms (11)

Synonym
C06115
l-arabinofuranose
CHEBI:6178
D7CE7DEF-6F98-4734-82A2-31EE7E9F9583
(3r,4r,5s)-5-(hydroxymethyl)oxolane-2,3,4-triol
arabinofuranose
7261-25-8
SCHEMBL447758
DTXSID40331542
Q27107116
(3r,4r,5s)-5-(hydroxymethyl)tetrahydrofuran-2,3,4-triol

Research Excerpts

Overview

D-Arabinofuranose is a major glycosyl constituent of mycobacteria. Found in two essential cell envelope heteropolysaccharides, arabinogalactan and lipoarabinomannan.

ExcerptReferenceRelevance
"D-Arabinofuranose is a major glycosyl constituent of mycobacteria found in two essential cell envelope heteropolysaccharides, arabinogalactan and lipoarabinomannan. "( Characterization of Arabinosyl Transfer Reactions in the Biosynthesis of Mycobacterial Cell Envelope (Lipo)Polysaccharides.
Angala, SK; Jackson, M, 2019
)
1.24

Bioavailability

ExcerptReferenceRelevance
" Such microbial degradation may be an important factor affecting the bioavailability of dietary FA."( Digestion and absorption of ferulic acid sugar esters in rat gastrointestinal tract.
Egashira, Y; Sanada, H; Zhao, Z, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
L-arabinoseThe L-enantiomer of arabinose.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (83)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.20)18.7374
1990's0 (0.00)18.2507
2000's26 (31.33)29.6817
2010's51 (61.45)24.3611
2020's5 (6.02)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.77 (24.57)
Research Supply Index4.43 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index46.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other81 (97.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]